delta133p53 inhibitor (NCI)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug Namedelta133p53 inhibitor (NCI)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTumor protein p53 inhibitors
TargetsTumor protein p53
Therapy Area/IndicationsHealthy AgingNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNational Cancer Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Institutes Of HealthNational Cancer Institute
Active IndicationsN/A
Inactive IndicationsHealthy AgingNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A